References
- Krane S, Muñoz A J, Harris E D. Urinary polypeptides related to collagen synthesis. J Clin Invest 1970; 49: 716–20
- Posen S, Cornish C, Kleerekoper M. Alkaline phosphatase and metabolic bone disorders. Metabolic Bone Disease, L V Avioli, S M Krane. Academic Press, New York 1977; 1: 141–52
- Lian J B, Canalis E. Biosynthesis and hormonal regulation of the vitamin K-dependent γ-carboxyglutamic acid containing bone protein. The Chemistry and Biology of Mineralized Tissues, W T Butler. EBSCO Media, Birmingham 1985; 326–31
- Gundberg C M, Gallop P M. Osteocalcin: the vitamin K-dependent protein of bone. Modification of Proteins During Aging, R C Adelman, E E Dekker. Alan R Liss Inc., New York 1985; 93–107
- Price P A, Williamson M K, Lothringer J W. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 1981; 256: 12760–6
- de la Piedra C, Rapado A, Esbrit P. Niveles séricos de osteocalcina en la hipercalcemia del hiperparatiroidismo primario y en la hipercalcemia tumoral. Rev Clin Esp 1985; 117: 310–3
- Esbrit P. Some recommendations to improve the quality of a radioimmunoassay for human parathyrin (Letter). Clin Chem 1984; 30: 1590
- Esbrit P, Babé M. Properties of different gel-filtration systems for the purification of 125I-labelled bovine parathyrin. Clin Chem 1981; 27: 1306–8
- Lowry O H, Roberts N R, Mei-Ling W V, Hixon W S, Crawford E J. The quantitative histochemistry of brain. Enzyme measurements. J Biol Chem 1954; 207: 19–37
- Henry R J. Química clínica. Bases y principios. JIMS, Barcelona 1969; 1: 347–65
- Kivirikko K I, Laitinen O, Prockop D J. Modifications of a specific assay for hydroxiproline in urine. Anal Biochem 1967; 19: 249–55
- Deftos L J, Parthemore J G, Price P A. Changes in plasma bone Gla-protein during treatment of bone disease. Calcif Tissue Int 1982; 34: 121–4
- Delmas P D, Demiaux B, Malaval L, Chapuy M C, Edouard C, Meunier P J. Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. J Clin Invest 1986; 77: 985–91
- Slovik D M, Gundberg C M, Neer R M, Lian J B. Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J Clin Endocrinol Metab 1984; 59: 228–50
- Delmas P D, Brown J P, Malaval L, Edward C, Meunier P J. Serum bone Gla-protein (BGP) compared to bone histomorphometry in postmenopausal osteoporosis: serum BGP can predict histological heterogeneity. Endocrine Control of Bone and Calcium Metabolism, D V Cohn, T Fujita, J T Potts, Jr., R V Talmage. Excerpta Medica, Amsterdam 1984; 73–7
- Deftos L J, Catherwood B D. BGP and bone metabolism. Clinical Disorders of Bone and Mineral Metabolism, B Frame, J T Potts, Jr. Excerpta Medica, Amsterdam 1983; 112–5
- Meunier P, Vignon G, Bernard J, Edouard C, Courpron P. Quantitative bone histology, as applied to the diagnosis of hyperparathyroid states. Clinical Aspects of Metabolic Bone Disease, B Frame, A M Parffit, H Duncan. Excerpta Medica, Amsterdam 1973; 215–21
- Mosekilde L, Melsen F. A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperparathyroidism and hyperthyroidism. Acta Med Scand 1978; 204: 97–102
- Stewart A, Vignery A, Silverglate A, Ravin N O, Livolsi V, Broadus A E, Baron A. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab 1982; 55: 219–27